Metabolomics

Dataset Information

0

Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model


ABSTRACT: This study aims to identify biomarkers for evaluating the therapeutic efficacy of mesalazine on ulcerative colitis by metabolomics and lipidomics. A dextran sulfate sodium-induced mouse model was used. The disease status was assessed by a disease activity index, the TNF-α level of colon was measured by an enzyme-linked immunosorbent assay, and the pathological changes of colon tissue was examined by hematoxylin-eosin staining. Serum metabolomics and lipidomics analysis based on ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry were applied to decipher the metabolic profile changes. Multivariate analysis was applied to differentiate the metabolites of controls, models, and mesalazine-treated mice. By the receiver operating characteristic (ROC) analysis, 40 differential metabolites with an area under curve (AUC) >0.80 were screened out between control and model groups. Among them, four potential biomarkers (palmitoyl glucuronide, isobutyrylglycine, PC (20:3 (5Z, 8Z, 11Z)/15:0) and L-arginine) had a signficantly reversed level of peak areas in the mesalazine group, and three of them were closely correlated with mesalazine efficacy by linear regression analysis. Furthermore, metabolic pathway analysis revealed several dysregulated pathways in colitis mice, including glycerophospholipid metabolism, pyrimidine metabolism, linoleic acid metabolism, arginine biosynthesis, etc. This study indicates that serum metabolomics is a useful approach that can noninvasively evaluate the therapeutic effect and provide unique insights into the underlying mechanism of mesalazine.

INSTRUMENT(S): UPLC-Q-TOF/MS (Positive), UPLC-Q-TOF/MS (Negative)

SUBMITTER: liu kun 

PROVIDER: MTBLS2111 | MetaboLights | 2022-10-24

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
MTBLS2111 Other
FILES Other
a_MTBLS2111_LC-MS_Lipid_NEG_metabolite_profiling.txt Txt
a_MTBLS2111_LC-MS_Lipid_Pos_metabolite_profiling.txt Txt
a_MTBLS2111_LC-MS_Meta_Neg_metabolite_profiling.txt Txt
Items per page:
1 - 5 of 10
altmetric image

Publications

Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model.

Liu Kun K   Jia Bingjie B   Zhou Liping L   Xing Lei L   Wu Lvying L   Li Yuanyuan Y   Lu Jungang J   Zhang Lei L   Guan Su S  

Journal of proteome research 20201223 2


This study aims to identify biomarkers for evaluating the therapeutic efficacy of mesalazine on ulcerative colitis by metabolomics and lipidomics. A dextran sulfate sodium-induced mouse model was used. The disease status was assessed by a disease activity index, the TNF-α level of colon was measured by an enzyme-linked immunosorbent assay, and the pathological changes of colon tissue was examined by hematoxylin-eosin staining. Serum metabolomics and lipidomics analysis based on ultraperformance  ...[more]

Similar Datasets

2023-07-24 | PXD043047 | Pride
2010-10-13 | E-GEOD-22307 | biostudies-arrayexpress
2020-03-17 | PXD007220 | Pride
2010-10-13 | GSE22307 | GEO
2016-07-31 | E-GEOD-71435 | biostudies-arrayexpress
2017-11-01 | GSE102389 | GEO
2019-11-12 | GSE96525 | GEO
2024-09-23 | PXD055368 | JPOST Repository
2012-06-27 | GSE34874 | GEO
2024-06-01 | GSE249870 | GEO